top of page
News, Events and Updates
Search
Jun 8, 2021
Anavex Life Sciences Announces Exceeding of Enrollment Target for the Precision Medicine ANAVEX®2-73
Jun 3, 2021
Anavex Life Sciences Announces Notice of Allowance for U.S. Patent Application ANAVEX®2-73
Mar 31, 2021
Anavex Life Sciences Reports Data Review by the Independent Data Safety Monitoring Board
Mar 16, 2021
Anavex Life Sciences Reports ANAVEX®2-73 featured as a Disease-Modifying Small Molecule in Trials
Aug 5, 2020
Anavex Life Sciences Receives TGA Special Access Scheme Approval for ANAVEX®2-73 for Alzheimer’s
Jun 4, 2020
Anavex Life Sciences Receives Approval from Health Canada & UK MHRA Expanding Phase 2b/3 ANAVEX®2-73
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
